Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Evangelia Farmaki"'
Autor:
Vasiliki Sgouropoulou, Maria Trachana, Jenny Pratsidou-Gertsi, Evangelia Farmaki, Theophanis Papadopoulos, Vasiliki Tzimouli
Publikováno v:
Rheumatology international. 42(1)
Familial Mediterranean Fever (FMF) is a genetic disorder of the innate immunity characterized by chronic inflammatory state. The diagnosis is mainly based on clinical criteria and supported by genotyping, especially in atypical phenotypes. The primar
Autor:
Ioannis Xinias, Anna Taparkou, Dimos Gidaris, Sofia Raftopoulou, Anil Dhawan, Natalia Nedelkopoulou, Evangelia Farmaki, Antigoni Mavroudi
Publikováno v:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and ImmunologyREFERENCES. 32(3)
BACKGROUND Interleukin 10 has been shown to play a critical role in the regulation of the immune responses in allergic diseases. AIM To investigate if genetic polymorphisms in the promoter region of the IL-10 gene are associated with food allergy (FA
Autor:
Eleni Papadimitriou, Anna Taparkou, Styliani Glykou, Eleni Agakidou, Evangelia Farmaki, F Kanakoudi-Tsakalidou, Fotiοs Papachristou
Publikováno v:
Vaccines
Volume 9
Issue 2
Vaccines, Vol 9, Iss 143, p 143 (2021)
Volume 9
Issue 2
Vaccines, Vol 9, Iss 143, p 143 (2021)
Measles outbreaks have surfaced in Europe during the last decades. Infants <
12 months of age were the most severely affected pediatric population. The aim of this study was to investigate the duration of maternally derived measles antibodies
12 months of age were the most severely affected pediatric population. The aim of this study was to investigate the duration of maternally derived measles antibodies
Autor:
Evangelia Farmaki, F Kanakoudi-Tsakalidou, Fotios Papachristou, Maria Trachana, Panayiota Nalbanti, Polyxeni Pratsidou-Gertsi, Panagiotis D. Bamidis
Publikováno v:
Rheumatology international. 38(7)
To assess longitudinally the course and outcome of juvenile idiopathic arthritis (JIA) in patients diagnosed and followed-up exclusively in the biologic era; also, to define possible predictors of the disease progression and need for early implementa
Autor:
Evangelia Farmaki, John O. Warner, Antonis Papastergiopulos, Elpis Hatziagorou, Elisavet-Anna Chrysochoou, John Tsanakas, Ioannis Xinias, Grigorios Kourentas, A. Karagiannidou, Fotios Kirvassilis, Antigoni Mavroudi, N. Karantaglis, Robert J. Boyle
Publikováno v:
Asian Pacific journal of allergy and immunology. 34(2)
Background: The Paediatric Allergic Rhinitis Quality of Life Questionnaire (Ped-AR-QoL) is the first tool developed for the assessment of health-related quality of life (QoL) in Greek children with allergic rhinitis (AR). Objective: The aim of the cu